Rezenopy
Product Images NDC 43674-004
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Rezenopy (NDC 43674-004). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Summit Biosciences Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Image 02)
Figure 2 (Image 03)
Ifu Figure A (Image 04)
Ifu Figure B-3 (Image 05)
Ifu Figure C-3 (Image 06)
Ifu Figure D (Image 07)
Ifu Figure E (Image 08)
Ifu Figure F (Image 09)
Ifu Figure G (Image 10)
Ifu Figure H (Image 11)
Ifu Figure I (Image 12)
Ifu Figure J (Image 13)
Ifu Figure K (Image 14)
Ifu Figure L (Image 15)
Principal Display Panel (Carton)
This text seems to be a description of a medication called "REZENOPY" which contains Naloxone Hydrochloride in a nasal spray form. It is meant for use in the nose only, with two nasal spray devices included, providing one dose per device. There are instructions not to remove from blister or test before use, and a reminder to check the product expiration date before usage. Pharmacists are instructed to dispense the entire carton at once. The text also mentions a quick start guide for using the product.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.